Evidence‐based nutritional and lifestyle strategies play a pivotal role to address key challenges around GLP‐1 treatment of obesity, making clinicians more effective in advancing their patients' health. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.